Modern Alpha Channel Biden’s “Cancer Moonshot” Brings Biotech Focus Back to U.S. By Karrie GordonSeptember 15, 2022
Disruptive Technology Channel Change the DNA of Your Portfolio: Growth Opportunities Through Genomics By Max ChenJune 7, 2022
Thematic Investing Channel Innovation Should Help Fuel Growth in This China Biotech ETF By Ben HernandezApril 11, 2022
Beyond Basic Beta Channel Vaccine Stocks Lift Biotech ETFs as China Enters Lockdowns By Max ChenMarch 14, 2022
Nasdaq Investment Intelligence Channel How to Invest in Biotech in 2022 By Karrie GordonDecember 15, 2021
Leveraged & Inverse Channel Direxion Launches mRNA Technology-Focused ETF By Karrie GordonDecember 9, 2021
Innovative ETFs Channel Moderna’s Omicron Booster Strategy Lifts Biotechnology ETFs By Max ChenNovember 29, 2021
Innovative ETFs Channel Pfizer’s COVID-19 Pill Has Mixed Results for Healthcare ETFs By Max ChenNovember 5, 2021
Innovative ETFs Channel Moderna Vaccine Is Granted Authorization in Australia By Max ChenAugust 9, 2021
Innovative ETFs Channel A Biotech ETF to Track Nasdaq’s Industry-Setting Benchmark By Max ChenJune 30, 2021
Modern Alpha Channel The BioRevolution: An ETF That Taps Into Nearly Everything By Max ChenJune 21, 2021
